Sign In
Buy BMY
$56.60
+1.88 (+3.44%)
At Close: Jun 04, 2026
5 Stocks I Sold Due To "Fragile Stagflation" Risk
07:21am, Friday, 28'th Jun 2024
Fragile stagflation presents challenges for investors, with limited opportunities for good returns in stocks and bonds. It is likely markets will experience a lost decade in real terms when measured f
You've Been Warned! 3 Pharma Stocks to Buy Now or Regret Forever.
01:14pm, Thursday, 27'th Jun 2024
The pharmaceutical market is a critical part of the healthcare industry. It contributes largely to research, development, production and distribution of important life-saving vaccines and medications.
Investors Heavily Search Bristol Myers Squibb Company (BMY): Here is What You Need to Know
10:06am, Thursday, 27'th Jun 2024
Bristol Myers (BMY) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Will Bristol Myers Squibb Stock Rebound To Its 2022 Highs Of $80?
08:00am, Wednesday, 26'th Jun 2024
Bristol Myers Squibb stock (NYSE: BMY) currently trades at $42 per share, 47% below its pre-inflation shock high of $80 seen in June 2022. In contrast, its peer – Merck stock – is up 56% over this
Bristol Myers Squibb (BMY) Stock Declines While Market Improves: Some Information for Investors
06:50pm, Tuesday, 25'th Jun 2024
In the closing of the recent trading day, Bristol Myers Squibb (BMY) stood at $42.19, denoting a -0.09% change from the preceding trading day.
Bristol Myers' (BMY) Krazati Gets FDA Nod for Colorectal Cancer
03:10pm, Monday, 24'th Jun 2024
Bristol Myers (BMY) wins FDA approval for Krazati, in combination with Erbitux, as a targeted treatment option for adult patients with KRASG12C-mutated locally advanced or metastatic colorectal cancer
7 Dividend Stocks to Buy Now: June 2024
01:38pm, Sunday, 23'rd Jun 2024
Income-oriented investors love finding dividend stocks to buy now. That's particularly true when those stocks are on sale, as many continue to be.
3 No-Brainer Stocks to Buy for Under $100 Right Now
07:15am, Saturday, 22'nd Jun 2024
AstraZeneca should have lots of growth ahead. Bristol Myers Squibb has what it takes to navigate a major patent cliff.
3 High-Yield Dividend Stocks Near Their 52-Week Lows to Buy and Hold
06:03am, Saturday, 22'nd Jun 2024
Pfizer has a lot of new drugs on the market, but its stock has been beaten down. Johnson & Johnson stock is down even though both its medical technology and pharmaceutical businesses reported signific
PRINCETON, N.J.--(BUSINESS WIRE)---- $BMY #BristolMyersSquibb--Bristol Myers Squibb Announces U.S. FDA Accelerated Approval of KRAZATI® (adagrasib) in Combination with Cetuximab for Adult Patients wi
US FDA approves Bristol Myers' colorectal cancer therapy
01:45pm, Friday, 21'st Jun 2024
The U.S. Food and Drug Administration has approved Bristol Myers Squibb's combination therapy for treating colorectal cancer in patients with a specific gene mutation, the health regulator's website s
European Medicines Agency Validates Bristol Myers Squibb's Application for Subcutaneous Nivolumab
06:59am, Friday, 21'st Jun 2024
PRINCETON, N.J.--(BUSINESS WIRE)---- $BMY #BristolMyersSquibb--European Medicines Agency Validates Bristol Myers Squibb's Application for Subcutaneous Nivolumab.
Bristol Myers Squibb to Report Results for Second Quarter 2024 on July 26, 2024
06:59am, Thursday, 20'th Jun 2024
PRINCETON, N.J.--(BUSINESS WIRE)--Bristol Myers Squibb to Report Results for Second Quarter 2024 on July 26, 2024.
3 Warren Buffett Stocks to Buy Now: June 2024
02:17pm, Wednesday, 19'th Jun 2024
Investors continue to look for the market to broaden before jumping in. They may be waiting awhile.
Bristol Myers Squibb Elects Michael R. McMullen to Board of Directors
04:16pm, Tuesday, 18'th Jun 2024
PRINCETON, N.J.--(BUSINESS WIRE)--Bristol Myers Squibb Elects Michael R. McMullen to Board of Directors.
